期刊
JOURNAL OF HEART AND LUNG TRANSPLANTATION
卷 34, 期 12, 页码 1495-1504出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2015.10.003
关键词
advanced heart failure; destination therapy; INTERMACS; mechanical support; ventricular assist device
资金
- National Heart, Lung and Blood Institute [HHSN2682011000250]
The seventh annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 9 years of patient enrollment. The Registry includes >15,000 patients from 158 participating hospitals. Trends in device strategy, patient profile at implant and survival are presented. Risk factors for mortality with continuous-flow pumps are updated, and the major causes/modes of death are presented. The adverse event burden is compared between eras, and health-related quality of life is reviewed. A detailed analysis of outcomes after mechanical circulatory support for ambulatory heart failure is presented. Recent summary data from PediMACS and MedaMACS is included. With the current continuous-flow devices, survival at 1 and 2 years is 80% and 70%, respectively. (C) 2015 International Society for Heart and Lung Transplantation. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据